Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penman Private Equity & Mezzanine Fund was a Chicago-based investment fund managed by Pennington Partners. Established in 1994, the fund specialized in providing growth capital and mezzanine financing to middle-market companies across various sectors, with a significant focus on healthcare services. One of its most notable investments was SVS Vision, a leading integrated provider of eyecare products and services, which the fund controlled until its sale to a management-led team in 2007. The fund is currently inactive and has been liquidated, having successfully exited its primary portfolio holdings. During its active period, it was a key player in the Midwestern private equity landscape, backed by major institutional investors such as CalPERS and the Oregon Public Employees Retirement Fund.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penman Private Equity.